Position in LH
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$587,720
+$62,905 QoQ
Shares Held
2,099
+6.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#550
of 1,040 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NorthRock Partners, LLC holds $3,877,725 across 6 Diagnostics & Research names. LH ranks #3 (15.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
5,560 | $1,059,068 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,994 | $999,711 | |
| 3 | LH |
Labcorp Holdings Inc.
This page
|
2,099 | $587,720 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
1,046 | $550,656 | |
| 5 | WAT |
Waters Corp /De/
|
1,118 | $419,294 | |
| 6 | A |
Agilent Technologies, Inc.
|
1,967 | $261,276 |
All Filings in LH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $587,720 | 2,099 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $524,815 | 1,967 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $469,396 | 1,871 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $813,240 | 2,833 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $219,983 | 838 | Shares | Sole | 2025-07-25 | |
| No filing history on record for this holder in this stock. | ||||||